Sunitinib bulk supplier for pharma manufacturers

Sunitinib Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 12.5 mg, 25 mg, 37.5 mg, 50 mg

Reference Brands: Sutent® (EU & US)

Sunitinib Tablets are oral oncology drugs used for renal cell carcinoma and GIST treatment. Available in 12.5 mg to 50 mg strengths, compliant with EU-GMP and USFDA standards. Ideal for B2B supply, private labeling, and hospital tenders across regulated markets.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Sunitinib Tablets are oral tyrosine kinase inhibitors used to treat renal cell carcinoma, gastrointestinal stromal tumors, and pancreatic neuroendocrine tumors. Available in 12.5 mg, 25 mg, 37.5 mg, and 50 mg film-coated tablets, our products comply with EU-GMP and USFDA standards. Offered for B2B supply, contract manufacturing, and private labeling, Sunitinib comes with full regulatory documentation including CTD dossiers and bioequivalence data. Trusted by distributors and hospital pharmacies across the US and EU, these tablets ensure consistent quality and efficacy for oncology treatment programs in regulated markets.

Sunitinib — third party manufacturing & bulk supply

Sunitinib is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Sunitinib is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Sunitinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Sunitinib →

Back to Listing

Frequently Asked Questions

Sunitinib is listed as Tablet in 12.5 mg, 25 mg, 37.5 mg, 50 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Sunitinib is referenced against Sutent® (EU & US). Reference brands are shown for identification only and remain the property of their respective trademark owners.